Cheng, Monica
Duzgol, Cihan
Kim, Tae-Hyung
Ghafoor, Soleen
Becker, Anton S.
Causa Andrieu, Pamela I.
Gangai, Natalie
Jiang, Hui
Hakimi, Abraham A.
Vargas, Hebert A.
Woo, Sungmin http://orcid.org/0000-0001-8459-8369
Funding for this research was provided by:
NIH/NCI (P30 CA008748)
Article History
Received: 5 August 2022
Accepted: 13 February 2023
First Online: 15 February 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board at Memorial Sloan Kettering Cancer Center, New York, NY and informed consent was waived.
: Not applicable. (retrospective).
: 1. Part of this study was presented as an oral paper at the International Cancer Imaging Society (ICIS) Meeting in Boston in September 2022.2. One of the authors (Abraham A. Hakimi) provides services to Merck & Co Inc., unrelated to the conduct of this manuscript. Otherwise, the authors declare no conflicts of interest regarding the publication of this study.